Skip to Content
Merck
CN

SML2454

Q151

≥98% (HPLC)

Synonym(s):

(2S)-N-[2-(4-cyanophenyl)-5-benzoxazolyl]-2-[(2,3-difluorophenyl)amino]propanamide, (S)-N-(2-(4-cyanophenyl)benzo[d]oxazol-5-yl)-2-((2,3-difluorophenyl)amino)propanamide

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

Empirical Formula (Hill Notation):
C23H16F2N4O2
CAS Number:
Molecular Weight:
418.40
UNSPSC Code:
51111800
NACRES:
NA.77
Assay:
≥98% (HPLC)
Form:
powder
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


assay

≥98% (HPLC)

form

powder

color

white to beige

solubility

DMSO: 2 mg/mL, clear

storage temp.

−20°C

SMILES string

FC1=C(N[C@@H](C)C(NC2=CC(N=C(C3=CC=C(C#N)C=C3)O4)=C4C=C2)=O)C=CC=C1F

InChI

1S/C23H16F2N4O2/c1-13(27-18-4-2-3-17(24)21(18)25)22(30)28-16-9-10-20-19(11-16)29-23(31-20)15-7-5-14(12-26)6-8-15/h2-11,13,27H,1H3,(H,28,30)/t13-/m0/s1

InChI key

QUSYLBPSSGPXBL-ZDUSSCGKSA-N

Biochem/physiol Actions

Inosine 5′-monophosphate dehydrogenase 2 (IMPDH2) inhibitor
Q151 is an inhibitor of bacterial inosine 5′-monophosphate dehydrogenase 2 (IMPDH2) with an IC50 value of 18 nM. It does not inhibit human IMPDH


Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

Regulatory Information

新产品

This item has



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



Shibin Chacko et al.
Journal of medicinal chemistry, 61(11), 4739-4756 (2018-05-11)
New drugs and molecular targets are urgently needed to address the emergence and spread of drug-resistant tuberculosis. Mycobacterium tuberculosis ( Mtb) inosine 5'-monophosphate dehydrogenase 2 ( MtbIMPDH2) is a promising yet controversial potential target. The inhibition of MtbIMPDH2 blocks the